Skip to main content

Natpara Update, March 22, 2022

HypoPARA Community,
On March 21, 2022, the HypoPARAthyroidism Association had a meeting with Takeda to get a status update on the Natpara recall. Unfortunately, the news we obtained was not what we were expecting. There will be additional delays in bringing Natpara back to the market. We have been assured that the delay will not affect the SUP already in place. Clicking the Takeda logo will take you to Takeda's sight for more information. We are currently working with Takeda to host a community engagement meeting during the first half of April 2022. We will communicate that date once it is confirmed. If you have any questions that you would like to ask Takeda regarding the delay, please send them to  

Bob Sanders, 
President, HPA